Annual Congress Amsterdam 2011

Saturday, 24.09.2011
Sunday, 25.09.2011
Monday, 26.09.2011
Tuesday, 27.09.2011
Wednesday, 28.09.2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

4205 Abstracts
632 Slide presentations
250 Webcasts
66 Handouts
1703 e-posters
250 Multimedia files

Material from 2011 Show

Innovative diagnostic methods for lung cancer

Oral Presentation
Chairs: A. Fisseler-Eckhoff (Wiesbaden, Germany), A. Scherpereel (Lille, France)

Download all media

Late-breaking abstract: Serum concentrations of new factors (IL-20, galectin 3, IL-29 and IL-33) involved in angiogenesis in patients with advanced non-small cell lung cancer (NSCLC) W. Naumnik, M. Ossolinska, K. Niewiarowska, E. Chyczewska (Bialystok, Poland)
Diagnostic accuracy of SELDI-TOF-MS (surface enhanced laser desabsorbtion ionization time of flight mass spectrometry) method in early diagnosis of lung cancer C. Simsek, O. Sönmez, A. Yurdakul, F. Özmen, N. Zengin, A. Keyf, D. Kubilay, O. Gülbahar, S. Karatayli, M. Bozdayi, C. Öztürk (Ankara, Turkey)
Bioconductance as adjunctive technique for evaluation of patients with lung masses detected by chest CT K. Callahan, R. Yung, M. Y. Zeng, M. Garff (Salt Lake City, Baltimore, United States Of America)
Amorfous components of the extracellular matrix have impact as new biochemical markers on malignancy characterization and prognosis of non-small cell lung cancer M. Peres Rangel, V. Karen de Sá, J. R. Maciel Martins, E. R. Parra, A. Mendes, D. Carrasco, E. Olivieri, V. L. Capelozzi (São Paulo, Brazil)
Interferon (-alpha, -beta, and -omega) receptor 2 (IFNAR2) is a prognostic biomarker for lung cancer N. Ishikawa, N. Hattori, S. Tanaka, Y. Horimasu, A. Yokoyama, N. Kohno (Hiroshima, Nankoku, Japan)
SHOX2 DNA methylation is a promising biomarker for the diagnosis of lung cancer in plasma B. Schmidt, C. Kneip, A. Seegebarth, M. Fleischhacker, V. Liebenberg, D. Dietrich (Halle, Mainz, Berlin, Germany)
Circulating tumor cells in chronic obstructive pulmonary disease patients C. Sanfiorenzo, K. Risso, V. Sellam, V. Hofman, M. Ilie, E. Long, E. Selva, C. Bonnetaud, C. H. Marquette, P. Hofman (Nice, France)
A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry J. I. Kurth, K. Darwiche, D. Theegarten, J. I. Baumbach, R. Purkhart, L. Freitag (Essen, Saarbruecken, Bernau, Germany)